Regenicin, Inc. (RGIN)
OTCMKTS · Delayed Price · Currency is USD
0.0001
+0.000099 (9,900.00%)
At close: Apr 24, 2026
Regenicin Market Cap
Regenicin has a market cap or net worth of $15.35 thousand as of July 31, 2026. Its market cap has increased by 9,931.37% in one year.
Market Cap
15.35K
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
ChartMarket Cap Chart
Since November 16, 2009, Regenicin's market cap has decreased from 2.17M to 15.35K, a decrease of -99.29%. That is a compound annual growth rate of -26.00%.
| Date | Market Cap | % Change |
|---|---|---|
| Apr 24, 2026 | 15.35K | 9,931.37% |
| Dec 31, 2025 | 153.00 | -99.80% |
| Dec 29, 2022 | 76.74K | -95.00% |
| Dec 31, 2021 | 1.53M | -33.99% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| IO Biotech | 21.59K |
| Scopus BioPharma | 21.04K |
| Health Sciences Group | 20.51K |
| Statera Biopharma | 14.52K |
| NanoLogix | 13.03K |
| Vaxxinity | 12.68K |
| ObsEva | 11.72K |
| Biostax | 10.77K |